News

Health Catalyst Welcomes Ben Albert as New President and COO

Health Catalyst Welcomes Ben Albert as New President and COO

Health Catalyst Welcomes Ben Albert as New President and COO

Albert Appointed to Drive Health Catalyst Forward in Its Next Chapter of Enabling Measurable Healthcare Improvement

Health Catalyst, Inc. (NASDAQ: HCAT), a prominent provider of data and analytics technology for healthcare organizations, is excited to announce the appointment of Ben Albert as its new President and Chief Operating Officer. Albert's role began following his leadership as the CEO and Co-Founder of Upfront Healthcare Services, Inc., which Health Catalyst acquired recently. His extensive experience spans over 25 years of fostering innovation within the healthcare landscape.

As he assumes this pivotal position, Albert will play an instrumental role in leading Health Catalyst through a crucial transformation period, steering everyday operations and crafting strategies that enhance the company’s long-term goals. He will oversee key areas, including Product Engineering, Technology Delivery, Support, Growth, Operations, Finance, and Corporate Strategy, reporting directly to him.

Collaboration and Leadership Transition

Working closely with Dan Burton, the current CEO, Albert is expected to facilitate a smooth operational transition as Burton prepares for his eventual retirement in mid-2026. This collaboration is anticipated to strengthen organizational alignment and ensure a steady course toward growth and stability.

Moreover, Dan LeSueur will complete his tenure with Health Catalyst, transitioning into a part-time advisory position to assist Albert during this change. Burton has expressed enthusiasm about Albert joining the leadership team, believing Albert's impressive background in leading technology companies that prioritize substantial returns on investment fits perfectly with Health Catalyst’s mission of achieving measurable healthcare improvement.

Vision for the Future

Albert expressed his excitement to step into this role, emphasizing the commitment of Health Catalyst to drive improvements that matter in the healthcare system. He highlighted the importance of a clear strategy, strong teamwork, and dedication among staff to ensure ongoing success for their clients.

Jack Kane, Chair of the Board, expressed gratitude for Albert's leadership. His belief is that Albert will escalate Health Catalyst's progress and enhance shareholder value, while also acknowledging the significant contributions of LeSueur and Burton throughout the years.

About Health Catalyst

Health Catalyst (Nasdaq: HCAT) stands out as a leader in healthcare innovation through data and analytics technology. The company empowers over 1,000 organizations globally with solutions like Health Catalyst Ignite™, aimed at transforming vast data sets into actionable insights. Health Catalyst is on a mission to help clients achieve meaningful improvements across clinical, financial, and operational metrics. Its reputation is built on delivering billions of dollars of measurable results, proving its commitment to the healthcare community.

Commitment to Change

Albert's appointment marks a significant step forward for Health Catalyst. His leadership style is rooted in collaboration, innovation, and a deep understanding of the healthcare environment, which positions him to lead the company toward its vision of creating a substantial impact on healthcare improvement.

As the company looks to the future, the leadership transition, combined with the robust technology offerings and unwavering commitment to customer success, reinforces Health Catalyst's dedication to being a catalyst for healthcare advancement.

Frequently Asked Questions

Who is Ben Albert?

Ben Albert is the newly appointed President and COO of Health Catalyst, previously serving as the CEO of Upfront Healthcare Services.

What are the responsibilities of the President and COO at Health Catalyst?

The President and COO oversees day-to-day operations, leads key departments, and helps shape the company’s long-term strategy and goals.

Who will Ben Albert be working closely with at Health Catalyst?

Albert will work closely with Dan Burton, the current CEO, as they transition leadership roles.

What is the mission of Health Catalyst?

Health Catalyst aims to enable massive and measurable healthcare improvement through its data and analytics technology and services.

How does Health Catalyst support its clients?

Health Catalyst provides innovative solutions that transform complex healthcare data into actionable insights, helping clients achieve operational success.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Triumph Financial Sets Stage for Q4 Earnings and Insights

Updated Category News Views 196

Triumph Financial Plans Fourth Quarter Earnings Release Triumph Financial, Inc. (Nasdaq: TFIN) recently announced its anticipation for the release of fourth quarter financial results. This event is scheduled to take place after the market closes on an upcoming Wednesday. Along with the financial report, the company will provide management commentary for stakeholders and...

Continue Reading
Monitoring ABA Therapy Progress: A Parent's Guide

Updated Category News Views 6

The Nuts and Bolts of Progress Monitoring You've got a situation in Leominster where parents are trying to make sense of ABA therapy's impact on their kids. Rob Shapiro, a big name in the ABA world, breaks it all down in a HelloNation article. We're talking about precise data collection being the backbone of measuring progress in ABA therapy. This ain't no place for...

Continue Reading
Understanding Dowlais Group's Recent Market Activities

Updated Category News Views 185

Public Disclosure Regarding Dowlais Group's Trading Activity FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree in relation to whose r

Continue Reading
OFS Credit Company Reports Impressive Q4 Financials for 2024

Updated Category News Views 98

OFS Credit Company Delivers Strong Q4 2024 Financial Results OFS Credit Company, Inc. (NASDAQ: OCCI), a notable investment firm focusing on collateralized loan obligation (CLO) equity and debt securities, has announced its financial performance for the fiscal quarter ending October 31, 2024. This report outlines the company’s significant financial growth and strategic...

Continue Reading
Breakthrough Data on HBI-8000 and Nivolumab for Melanoma

Updated Category News Views 89

HBI-8000 and Nivolumab: A New Era in Melanoma Treatment Recent findings highlight the potential of HBI-8000 in combination with nivolumab, suggesting a transformative approach in the treatment of advanced melanoma. This promising combination will be discussed in detail at an upcoming prestigious annual meeting focused on advancements in immunotherapy. Innovative Solutions...

Continue Reading